This report summarizes findings from two studies from 2017 that looked at risk factors associated with the development of neonatal withdrawal syndrome (also known as neonatal abstinence syndrome) in babies born to mothers with opioid use disorder. Published in the National Institute on Drug Abuse research notes.
This 2017 report from the Association for Community Affiliated Plans describes innovative practices designed to address opioid misuse and treat opioid use disorder (OUD) implemented in 5 Medicaid managed care organizations across the country. The practices focus on prevention and detection of misuse of
Sally’s story details her opioid use, which began following dental surgery at 14 and escalated into adulthood until she lost her job and was no longer able to support herself. At age 20, she began 3 years of treatment and relapses and became stabilized and in recovery after joining a methadone treatment program.
Since 2013, Minnesota has been in process of changing the state’s approach to substance use disorder treatment from an episodic model of treatment to a chronic disease longitudinal systems of care model. This 2018 report builds upon previous recommendations with a focus on workforce development, person
This report from the National Governors Association’s Center for Best Practices focuses on strategies states can use to ensure access to pharmaceutical treatments needed to address public health crises. The report addresses opioid related treatment such as medication assisted treatment for opioid use disorder
The Arizona Department of Health Services created these frequently asked questions to explain the state requirement that health care providers report cases of neonatal opioid withdrawal (or neonatal abstinence syndrome) as part of the state’s enhanced opioid surveillance.
A report from a 12 state learning collaborative on improving treatment of opioid use disorder among pregnant and parenting women and infants exposed to opioids. The report focuses on the strategies states used to expand access to and coordination of services, improve education and training for providers, use data to monitor and evaluate initiatives, enhance medical coverage and reimbursement policies, and address ethical, legal, and social considerations such as stigma.